Annovis Bio Inc (NYSE:ANVS) currently has a daily average trading volume of 471.79K but it saw 930745 shares traded in last market. With a market cap of 45.02M USD, the company’s current market price of $2.31 came falling about -6.85 while comparing to the previous closing price of $2.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $20.00 and as low as $2.44.
Taking a look at 20-day trading activity of Annovis Bio Inc (ANVS) gives us an average price of $3.66, while its current price level is -88.45% below from 52-week high level whereas it is -5.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.55 while that of 200 days or SMA-200 reads an average of $7.28. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.27% during that period while stretching the period over a month that increases to 9.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.91 which implies that the stock is in oversold territory.
Maxim Group upgraded its recommendation for the stock as a “Buy” from “Hold” on October 25, 2024 while assigning a price target of $25. Canaccord Genuity issued its recommendations for the stock as it initiated the price target for the stock is $36.
Over the week, ANVS’s stock price is moving -8.33% down while it is -53.89% when we observe its performance for the past one month. Year-to-date it is -54.08% down and over the past year, the stock is showing a downside performance of -79.52%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.2 while estimate for next year EPS is -1.71.
Currently, Annovis Bio Inc’s total number of outstanding shares is 19.49M with 14.45% of that held by the insiders while 13.30% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -579.57% and return on equity (ROE) at -596.70%. Stock’s beta reads 1.53. Stock has a price to book (P/B) ratio of 4.34. Its return on asset (ROA) is -333.05% on average.
